GO
Loading...

Blackstone Unit to Acquire DJO for $1.3 Billion

A unit of private equity giant Blackstone Groupwill buy knee and ankle brace maker DJOfor $1.3 billion, the companies said on Monday.

The cash offer of $50.25 per share represents a 19 percent premium over DJO's closing price of $42.10 on Friday.

The deal will bring together DJO and medical device maker ReAble Therapeutics, formerly known as Encore Medical. The companies make complementary orthopedic and pain-management products, DJO said.

A Blackstone affiliate is the controlling shareholder of ReAble. The affiliate will provide the equity financing for the deal.

Biomet, a much larger orthopedic products maker, last month agreed to a sweetened takeover bid of $11.4 billion from a group of private equity firms that includes Blackstone.

The DJO transaction is worth $1.6 billion, including $300 million of assumed debt, and is expected to close in the fourth quarter.

DJO will have to pay ReAble a break-up fee of $18.7 million if the deal falls through. The DJO board has unanimously approved the transaction.

Wachovia Securities is the financial advisor to DJO, while Credit Suisse is advising ReAble and Blackstone.

Contact U.S. News

  • CNBC NEWSLETTERS

    Get the best of CNBC in your inbox

    To learn more about how we use your information,
    please read our Privacy Policy.
    › Learn More

Don't Miss

U.S. Video

  • If you're a CEO, you're being challenged, says Jim Cramer, explaining what he is watching ahead of the open. Stick with the restaurants, suggests Cramer.

  • Don't start your trading day without finding out what CNBC's Jim Cramer is watching ahead of the opening bell. Today, he says Greece is what happens when Germany is too stringent.

  • Microsoft to report earnings after the bell Monday. We zero in on what investors should expect.